| Dr Thomas Lam, MD | |
|
1703 S Meridian Ste 101, Puyallup, WA 98371-7590 | |
| (253) 848-3000 | |
| Not Available |
| Full Name | Dr Thomas Lam |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 1703 S Meridian Ste 101, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699194175 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 01075734A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cascade Eye And Skin Centers P.c. | 4486541554 | 38 |
News Archive
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present.
With increasing numbers of men and women serving in combat and risking traumatic injury and limb loss, a new study published in The Journal of Pain, the peer-reviewed publication of the American Pain Society, concludes that self-reported amputation-specific pain severity is similar in men and women but there are considerable gender variations in overall pain outcomes, such as emotional health and pain-coping responses.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 5 days ago
| Entity Name | Virginia Mason Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801851258 PECOS PAC ID: 9830002617 Enrollment ID: O20031107000383 |
News Archive
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present.
With increasing numbers of men and women serving in combat and risking traumatic injury and limb loss, a new study published in The Journal of Pain, the peer-reviewed publication of the American Pain Society, concludes that self-reported amputation-specific pain severity is similar in men and women but there are considerable gender variations in overall pain outcomes, such as emotional health and pain-coping responses.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 5 days ago
| Entity Name | Cascade Eye & Skin Centers P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033204938 PECOS PAC ID: 4486541554 Enrollment ID: O20040310000465 |
News Archive
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present.
With increasing numbers of men and women serving in combat and risking traumatic injury and limb loss, a new study published in The Journal of Pain, the peer-reviewed publication of the American Pain Society, concludes that self-reported amputation-specific pain severity is similar in men and women but there are considerable gender variations in overall pain outcomes, such as emotional health and pain-coping responses.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 5 days ago
| Entity Name | Pace Dermatology Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922398585 PECOS PAC ID: 5193995777 Enrollment ID: O20110909002697 |
News Archive
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present.
With increasing numbers of men and women serving in combat and risking traumatic injury and limb loss, a new study published in The Journal of Pain, the peer-reviewed publication of the American Pain Society, concludes that self-reported amputation-specific pain severity is similar in men and women but there are considerable gender variations in overall pain outcomes, such as emotional health and pain-coping responses.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Lam, MD 1703 S Meridian Ste 101, Puyallup, WA 98371-7590 Ph: (253) 848-3000 | Dr Thomas Lam, MD 1703 S Meridian Ste 101, Puyallup, WA 98371-7590 Ph: (253) 848-3000 |
News Archive
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present.
With increasing numbers of men and women serving in combat and risking traumatic injury and limb loss, a new study published in The Journal of Pain, the peer-reviewed publication of the American Pain Society, concludes that self-reported amputation-specific pain severity is similar in men and women but there are considerable gender variations in overall pain outcomes, such as emotional health and pain-coping responses.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 5 days ago
Barbara J Fox, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1703 S Meridian, Suite 101, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-840-6514 | |
June Kim, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1703 Meridian St S Ste 101, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-840-6514 | |
Susan L. Sullivan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1703 S Meridian Ste 101, Puyallup, WA 98371 Phone: 253-446-3903 Fax: 253-840-6514 | |
Dr. Dan Algot Wiklund, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 929 E Main Ave, Suite 210, Puyallup, WA 98372 Phone: 253-848-9563 Fax: 253-840-5519 | |
Dr. Jeffrey Stephen Newman, M.D., PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 929 E Main Ave, Suite 210, Puyallup, WA 98372 Phone: 253-841-2453 Fax: 253-840-5519 | |
Brenda F Kodama, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1703 S Meridian, Ste 101, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-840-6514 |